Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Multiscale assessment of the amyloid assembly of MICRObiota-associated Bap proteins and the intermolecular templating of alpha-SYNuclein fibrils

Descrizione del progetto

Fattore microbico scatenante del morbo di Parkinson

Il morbo di Parkinson (MP) è una malattia neurodegenerativa caratterizzata da un’aggregazione patologica di alfa-sinucleina. Nuove prove indicano un legame tra il microbiota intestinale e l’alfa-sinucleina. Con il supporto del programma di azioni Marie Skłodowska-Curie, il progetto MICROSYN si propone di studiare in che modo le proteine associate ai biofilm (Bap) secrete dai batteri possano innescare l’aggregazione dell’alfa-sinucleina. I ricercatori si concentreranno sulla BapSa dello Staphylococcus aureus e sulla Esp dell’Enterococcus faecalis e ne scopriranno la struttura fibrillare. Utilizzando la microscopia a forza atomica, studieranno le interazioni di queste proteine con l’alfa-sinucleina. I risultati potrebbero aprire la strada a nuove strategie terapeutiche per il morbo di Parkinson, nonché ad agenti anti-biofilm per contrastare la resistenza antimicrobica.

Obiettivo

The global rise in Parkinson’s disease (PD) and other neurodegenerative disorders is becoming an important public health concern in the European Union and worldwide. Recent discoveries have revealed a direct connection between biofilm-associated proteins (Baps) from the human microbiota and alpha-synuclein (alpha-Syn) aggregation - a pathological hallmark of PD - supporting the hypothesis that the gastrointestinal tract plays a role in the pathogenesis of neurodegenerative diseases. The MICROSYN project aims to investigate the molecular mechanisms behind the impact of Bap proteins - BapSa from Staphylococcus aureus and Esp from Enterococcus faecalis - on the aberrant assembly of alpha-Syn. Currently, structural models of BapSa and Esp amyloid fibrils and the intermolecular interactions during the templating of alpha-Syn aggregation are unknown.
Utilizing the state-of-the art techniques magic angle spinning solid-state nuclear magnetic resonance and atomic force microscopy, this project will provide atomic-level information on Bap and Esp amyloid fibril structure and dynamics, reveal conformational changes upon cross-seeding with alpha-Syn, and offer valuable insights into the fibril architectures at the mesoscopic scale. This will be achieved through the expertise of Dr. Álvarez-Mena in the biochemistry and molecular biology of bacterial amyloids, combined with the host lab know-how in solid-state NMR, AFM and complementary physico-chemical techniques, supported by the cutting-edge facilities of the host institution.
Understanding the interaction between microbiota-derived BapSa/Esp and human alpha-Syn will offer new therapeutic avenues for combating PD, while insights into the structures of BapSa and Esp fibrils will aid in developing antimicrobial and antibiofilm agents to tackle antibiotic resistance. Thus, the MICROSYN project will support EU health priorities by fostering innovation in disease prevention and treatment.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2024-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Contributo netto dell'UE
€ 226 420,56
Indirizzo
RUE MICHEL ANGE 3
75794 Paris
Francia
Regione
Ile-de-France Ile-de-France Paris
Tipo di attività
Research Organisations
Collegamenti
Costo totale
Nessun dato